NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

Treatment with three low-dose agents in single pill linked to lower incidence of recurrent stroke, major cardiovascular events in patients with hemorrhagic stroke ...

A new study suggests that a novel anti-clotting drug may reduce the risk of a second stroke without increasing bleeding, ...

Nearly 2 million brain cells die each minute a stroke remains untreated. We break down the biggest advances in stroke care ...

Though minutes can make all the difference in the treatment of people having strokes, many of them are seeking help at hospital and other treatment centers hours later than they did before the ...

STROKE trial show a 26% reduction in recurrent stroke with the factor XIa inhibitor asundexian, with no increased bleeding ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.

One in seven stroke patients in India falls in the 18-44 age group, while two in five reach hospital more than 24 hours after ...

The Joint Commission has released a free, downloadable brochure on the topic of stroke prevention and treatment. The brochure, titled “Speak Up: ‘What You Should Know About Stroke,'” was developed by ...